Smith & Nephew and OrthoSensor to co-market orthopedic surgical tech and tools

Smith & Nephew ($SNN) has inked a co-marketing deal with OrthoSensor involving one of the company's orthopedic surgical tools. Neither side is discussing financial details. But the deal allows joint marketing of OrthoSensor's Verasense sensor-assisted surgery tech for soft tissue balancing with Smith & Nephew's Journey II and Legion total knee replacement systems. U.K.-based Smith & Nephew gains added selling points with the joint deal, and Florida-based OrthoSensor once again gets to reach a larger audience through a partnership with a global company. Last November, OrthoSensor sealed a co-marketing deal with Zimmer ($ZMH) that allowed Zimmer's knee systems to be marketed with Verasense, which uses sensors to wirelessly transmit data to surgeons so they can achieve a more balanced knee implant fit. Release

Suggested Articles

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.